Pharmaceutical companies are using their savings from recent corporate tax cuts to buy back shares of their own stock, enriching executives and wealthy investors as prescription drug prices continue to skyrocket, says Robert Reich, former Secretary of Labor.
“It’s a two part scam,” he said. “Pharma executives gouge the public with higher drug prices while Trump and Republicans line their pockets with bigger tax cuts.”
Listen to the rest of his insight below.